News
7d
Clinical Trials Arena on MSNAstraZeneca’s AL amyloidosis drug fails to impress in Phase III"AstraZeneca’s AL amyloidosis drug fails to impress in Phase III" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
7d
Zacks Investment Research on MSNAstraZeneca's AL Amyloidosis Drug Misses Goal in Late-Stage StudiesAstraZeneca AZN reported disappointing results from two late-stage studies that evaluated its investigational light chain ...
A new AI model accurately detected cardiac amyloidosis from echocardiograms with higher accuracy vs. other amyloidosis risk ...
AstraZeneca's experimental therapy anselamimab did not meet the main goal of a late-stage study for the treatment of a rare ...
In this video, Shahzad Raza, MD, discusses teclistamab as a potential treatment for patients with relapsed or refractory systemic light chain amyloidosis.“Teclistamab has already been approved in ...
Amyloidosis is a group of conditions that cause an abnormal protein called amyloid to build up in the body. Treatment depends on the type of amyloidosis but may include medications and organ ...
Amyloidosis is a rare category of disorders in which various cells in your body function abnormally, leading to the buildup of amyloid protein. Symptoms, prognosis, diagnosis, and treatment depend ...
So, amyloidosis, there are several types, several causes, and several symptoms, so you need a comprehensive team to get together and put this puzzle together. Interviewer: Yeah, and we have a clinic ...
Amyloidosis is a condition that affects various body tissues and organs. Learn 8 ways it affects the body, and what you can do to manage these symptoms.
AL amyloidosis can be found in newly diagnosed 2 patients with MM or can develop later in their disease course, 16 which bodes poorly for these patients. 17 Historically, the converse—that is, ...
This type of amyloidosis is also progressive but much more slowly. The patient was referred to a cardiothoracic surgeon at Columbia University. Sooner or later, he was going to need a heart ...
Amyloidosis is a rare and possibly life-threatening disease affecting an estimated 4,000 people per year in the US. If left untreated, the disease can cause severe organ damage, so early detection is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results